| Nome |
# |
|
Challenges in the physical characterization of lipid nanoparticles, file e309ade4-a422-3969-e053-3a05fe0a2c94
|
139
|
|
L-dopa co-drugs in nanostructured lipid carriers: a comparative study, file e309ade3-ad57-3969-e053-3a05fe0a2c94
|
98
|
|
Progesterone lipid nanoparticles: Scaling up and in vivo human study, file e309ade3-d317-3969-e053-3a05fe0a2c94
|
76
|
|
Encapsulation of cannabinoid drugs in nanostructured lipid carriers, file e309ade3-b23c-3969-e053-3a05fe0a2c94
|
74
|
|
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study, file e309ade3-b234-3969-e053-3a05fe0a2c94
|
70
|
|
Nanostructured lipid systems modified with waste material of propolis for wound healing: design, in vitro and in vivo evaluation, file e309ade3-bff0-3969-e053-3a05fe0a2c94
|
66
|
|
Monoolein Aqueous Dispersions as a delivery system for quercetin, file e309ade3-a673-3969-e053-3a05fe0a2c94
|
64
|
|
Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior, file e309ade3-ee77-3969-e053-3a05fe0a2c94
|
60
|
|
Design and characterization of ethosomes for transdermal delivery of caffeic acid, file e309ade2-b007-3969-e053-3a05fe0a2c94
|
59
|
|
A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles, file e309ade2-9f5e-3969-e053-3a05fe0a2c94
|
54
|
|
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs, file e309ade3-a081-3969-e053-3a05fe0a2c94
|
53
|
|
Aminated polysaccharide microspheres as DNA delivery systems, file e309ade4-79d7-3969-e053-3a05fe0a2c94
|
52
|
|
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies, file e309ade3-9657-3969-e053-3a05fe0a2c94
|
49
|
|
Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study, file e309ade3-295b-3969-e053-3a05fe0a2c94
|
47
|
|
Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.), file e309ade3-baa3-3969-e053-3a05fe0a2c94
|
47
|
|
Production and characterization of clotrimazole liposphere gel for candidiasis treatment, file e309ade3-91b7-3969-e053-3a05fe0a2c94
|
46
|
|
Effect of new Curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses, file e309ade3-df00-3969-e053-3a05fe0a2c94
|
46
|
|
Ellagic acid containing Nanostructured Lipid Carriers for topical application: a preliminary study, file e309ade2-9f5d-3969-e053-3a05fe0a2c94
|
44
|
|
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates, file e309ade3-b550-3969-e053-3a05fe0a2c94
|
43
|
|
Lipid nanostructures for antioxidant delivery: A comparative preformulation study, file e309ade4-a066-3969-e053-3a05fe0a2c94
|
43
|
|
Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies, file e309ade3-ec26-3969-e053-3a05fe0a2c94
|
38
|
|
Monoolein liquid crystalline phases for topical delivery of crocetin, file e309ade3-da28-3969-e053-3a05fe0a2c94
|
34
|
|
Lipid nanocarriers containing a Levodopa prodrug with potential antiparkinsonian activity, file e309ade3-fe3e-3969-e053-3a05fe0a2c94
|
34
|
|
Ethosomes and organogels for cutaneous administration of crocin, file e309ade3-dc44-3969-e053-3a05fe0a2c94
|
33
|
|
Biodistribution of nanostructured lipid carriers: a tomographic study, file e309ade3-e278-3969-e053-3a05fe0a2c94
|
27
|
|
"Plurethosome" as vesicular system for cutaneous administration of mangiferin: formulative study and 3D skin tissue evaluation, file e309ade4-cd68-3969-e053-3a05fe0a2c94
|
23
|
|
Nanoparticulate gels for cutaneous administration of caffeic acid, file e309ade2-aa27-3969-e053-3a05fe0a2c94
|
19
|
|
Lipid-Based Nanosystems for the Topical Application of Ferulic Acid: A Comparative Study, file 216e1a04-bafa-4e90-bad6-aec1cfcb98b9
|
16
|
|
Ethosomes for coenzyme Q10 cutaneous administration: from design to 3D skin tissue evaluation, file e309ade2-b005-3969-e053-3a05fe0a2c94
|
14
|
|
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy, file e309ade5-84e6-3969-e053-3a05fe0a2c94
|
12
|
|
The potential of caffeic acid lipid nanoparticulate systems for skin application: in vitro assays to assess delivery and antioxidant effect, file e309ade3-292a-3969-e053-3a05fe0a2c94
|
11
|
|
Ethosomes and transethosomes for mangiferin transdermal delivery, file e309ade4-7298-3969-e053-3a05fe0a2c94
|
11
|
|
Synthetic and nanotechnological approaches for a diagnostic use of manganese, file e309ade5-65e7-3969-e053-3a05fe0a2c94
|
11
|
|
Lipid-based nanosystems as a tool to overcome skin barrier, file e309ade4-cd6a-3969-e053-3a05fe0a2c94
|
10
|
|
Design of liposomes carrying HelixComplex Snail Mucus: preliminary studies, file e309ade4-cd6c-3969-e053-3a05fe0a2c94
|
10
|
|
Mangiferin loaded smart gels for HSV-1 treatment, file e309ade4-cd6e-3969-e053-3a05fe0a2c94
|
8
|
|
Ethosomes and transethosomes as cutaneous delivery systems for quercetin: a preliminary study on melanoma cells, file e309ade5-5473-3969-e053-3a05fe0a2c94
|
7
|
|
Biodistribution of nanostructured lipid carriers: a tomographic study, file e309ade2-cd7f-3969-e053-3a05fe0a2c94
|
5
|
|
Manganese in diagnostics: A preformulatory study, file e309ade5-0ee3-3969-e053-3a05fe0a2c94
|
4
|
|
Spectrofluorometric analysis to evaluate transcutaneous biodistribution of fluorescent nanoparticulate gel formulations, file e309ade5-1cb6-3969-e053-3a05fe0a2c94
|
4
|
|
Niosomes for Topical Application of Antioxidant Molecules: Design and In Vitro Behavior, file 013aa2e2-283f-4ad3-8203-6fbf069a69bc
|
3
|
|
Ethosomes and organogels for cutaneous administration of crocin, file e309ade0-ebf5-3969-e053-3a05fe0a2c94
|
3
|
|
Monoolein Aqueous Dispersions as a delivery system for quercetin, file e309ade3-23ea-3969-e053-3a05fe0a2c94
|
3
|
|
Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies, file e309ade3-ec25-3969-e053-3a05fe0a2c94
|
3
|
|
Bilosomes and Biloparticles for the Delivery of Lipophilic Drugs: A Preliminary Study, file 86f3faa7-1984-447d-81b0-8c09c0416cf6
|
2
|
|
Thermal magnetic field activated propolis release from liquid crystalline system based on magnetic nanoparticles, file e309ade2-1ba2-3969-e053-3a05fe0a2c94
|
2
|
|
L-dopa co-drugs in nanostructured lipid carriers: a comparative study, file e309ade3-980a-3969-e053-3a05fe0a2c94
|
2
|
|
Antioxidant-containing monoolein aqueous dispersions: a preliminary study, file e309ade5-55ba-3969-e053-3a05fe0a2c94
|
2
|
|
Antioxidant-containing monoolein aqueous dispersions: a preliminary study, file ca00d3fa-6c94-433f-bb0b-cdbb1e0debae
|
1
|
|
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin, file e309ade0-2c05-3969-e053-3a05fe0a2c94
|
1
|
|
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors, file e309ade0-32b3-3969-e053-3a05fe0a2c94
|
1
|
|
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity, file e309ade0-ebe9-3969-e053-3a05fe0a2c94
|
1
|
|
Encapsulation of cannabinoid drugs in nanostructured lipid carriers, file e309ade0-ebf2-3969-e053-3a05fe0a2c94
|
1
|
|
Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappa B transcription factors, file e309ade0-f553-3969-e053-3a05fe0a2c94
|
1
|
|
Progesterone lipid nanoparticles: Scaling up and in vivo human study, file e309ade2-ade1-3969-e053-3a05fe0a2c94
|
1
|
|
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study, file e309ade3-8e11-3969-e053-3a05fe0a2c94
|
1
|
|
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs, file e309ade3-9844-3969-e053-3a05fe0a2c94
|
1
|
|
New delivery systems for quercetin, file e309ade4-b96d-3969-e053-3a05fe0a2c94
|
1
|
| Totale |
1.591 |